Statement from ACI founder Steve Moore

It has been quite a start to 2020 across our sector, with significant regulatory developments in both the medicinal cannabis and the CBD wellness space.

However, right now we all have to adapt to a new world and the unprecedented challenge a global pandemic presents us all.

CBD Poll Data (March 2020)

Fieldwork dates: 6th-9th March 2020Total sample size: 2065 adultsConducted by: YouGovOn Behalf of: The Association for the Cannabinoid Industry This survey data was collected and analysed by YouGov plc.  Please see the related press release : New Poll Finds Overwhelming Public Support For FSA CBD Regulation (11 March 2020) Methodology  This survey has been conducted […]

[PodBean] Podcast: The ACI experts discuss the recent FSA CBD announcement

Hayden Williamson from the Podcast CBD ReLeaf chats with The ACI Regulatory and Compliance Lead, Dr Parveen Bhatarah, The ACI Development Director, Shomi Malik, and Global Regulatory Services Dr Sarah Gaunt about the recent announcement from The Foods Standards Agency (FSA) regarding CBD. For more details on this see our FAQ.